Tumor Retention of 186 Re-MAG3, 111 In-DTPA and 125 I Labeled Monoclonal Antibody G250 in Nude Mice with Renal Cell Carcinoma Xenografts

Saved in:
Bibliographic Details
Published inCancer biotherapy & radiopharmaceuticals Vol. 13; no. 2; pp. 133 - 139
Main Authors Steffens, M.G., Kranenborg, M.H.G.C., Boerman, O.C., Zegwaart-Hagemeier, N.E.M., Debruyne, F.M.J., Corstens, F.H.M., Oosterwijk, E.
Format Journal Article
LanguageEnglish
Published 01.04.1998
Online AccessGet more information

Cover

Author Boerman, O.C.
Zegwaart-Hagemeier, N.E.M.
Kranenborg, M.H.G.C.
Oosterwijk, E.
Steffens, M.G.
Corstens, F.H.M.
Debruyne, F.M.J.
Author_xml – sequence: 1
  givenname: M.G.
  surname: Steffens
  fullname: Steffens, M.G.
– sequence: 2
  givenname: M.H.G.C.
  surname: Kranenborg
  fullname: Kranenborg, M.H.G.C.
– sequence: 3
  givenname: O.C.
  surname: Boerman
  fullname: Boerman, O.C.
– sequence: 4
  givenname: N.E.M.
  surname: Zegwaart-Hagemeier
  fullname: Zegwaart-Hagemeier, N.E.M.
– sequence: 5
  givenname: F.M.J.
  surname: Debruyne
  fullname: Debruyne, F.M.J.
– sequence: 6
  givenname: F.H.M.
  surname: Corstens
  fullname: Corstens, F.H.M.
– sequence: 7
  givenname: E.
  surname: Oosterwijk
  fullname: Oosterwijk, E.
BookMark eNp1kM9KAzEQh4MoWKtnr_MAbptJTJocS9VaaFWkB29L_q2ubBPJrohv4GOboidBGGaGYb7f4TshhzHFQMg50glSpafO5glqrSbIS_EDMkIhZpVSgh2WnarLSs-UOCYnff9KKZVUzkbka_u-SxkewxDi0KYIqQFUshyqzXzJLwARYRWrq-3DHEz0gEzACtbGhi542KSYXJei6WBeeJv8JyyZoNBGuHv3ATatC_DRDi8lcf-1CF1pJrs2pp2BpxDTczbN0J-So8Z0fTj7nWOyvbneLm6r9f1ytZivK6ckr7STBnHmvZYyMG-D5rJxKDhzhkumGTbBM6V4g5o2wgrrvWTSXDJrGTWWjsn0J9bl1Pc5NPVbbncmf9ZI673Hunis9x5r5KV4IcQfwrWD2bsasmm7f7lvV1p27A
CitedBy_id crossref_primary_10_1007_s00259_009_1268_9
crossref_primary_10_1002_med_21497
crossref_primary_10_1016_j_neo_2014_12_011
crossref_primary_10_1186_s41181_020_00094_w
crossref_primary_10_1007_s00259_006_0152_0
crossref_primary_10_1016_S0094_0143_03_00028_4
crossref_primary_10_1007_s11912_005_0036_7
crossref_primary_10_1089_108497803322287745
crossref_primary_10_1002_ijc_10369
crossref_primary_10_1002_ijc_11304
crossref_primary_10_1016_j_bbrc_2014_02_086
crossref_primary_10_1089_108497803322287592
Cites_doi 10.1016/0006-291X(78)91322-0
10.1200/JCO.1996.14.7.1974
10.1016/0022-1759(84)90435-6
10.1002/(SICI)1097-0215(19970729)72:3<477::AID-IJC16>3.0.CO;2-9
10.1002/(SICI)1097-0142(19971215)80:12+<2390::AID-CNCR9>3.0.CO;2-F
10.1002/ijc.2910380406
10.1002/1097-0142(19930601)71:11<3478::AID-CNCR2820711104>3.0.CO;2-A
10.1016/S0140-6736(95)92225-3
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1089/cbr.1998.13.133
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1557-8852
EndPage 139
ExternalDocumentID 10_1089_cbr_1998_13_133
n/a
GroupedDBID ---
.GJ
0R~
1-M
29B
34G
39C
3V.
4.4
53G
5GY
5RE
6PF
7X7
88A
88E
88I
8C1
8FE
8FH
8FI
8FJ
8WZ
A6W
AAWTL
AAYXX
ABBKN
ABJNI
ABUWG
ACGFS
ACGOD
ACPRK
ADBBV
AENEX
AFKRA
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BBNVY
BENPR
BHPHI
BNQNF
BPHCQ
BVXVI
CAG
CCPQU
CITATION
COF
CS3
DU5
DWQXO
EBS
EJD
F5P
FYUFA
GNUQQ
HCIFZ
HMCUK
IAO
IHR
IM4
INH
INR
ITC
L7B
LK8
M0L
M1P
M2P
M7P
O9-
P2P
PQQKQ
PROAC
PSQYO
RIG
RML
RMSOB
UDS
UE5
UKHRP
ZGI
ID FETCH-LOGICAL-c863-9c6a117dd966e2dbe936fc1532ca362921fed2883f190f5b5bdd626a42bb20ab0
ISSN 1084-9785
IngestDate Fri Aug 23 02:03:53 EDT 2024
Tue Jul 23 14:28:40 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c863-9c6a117dd966e2dbe936fc1532ca362921fed2883f190f5b5bdd626a42bb20ab0
PageCount 7
ParticipantIDs crossref_primary_10_1089_cbr_1998_13_133
crossref_citationtrail_10_1089_cbr_1998_13_133
PublicationCentury 1900
PublicationDate 1998-04-00
PublicationDateYYYYMMDD 1998-04-01
PublicationDate_xml – month: 04
  year: 1998
  text: 1998-04-00
PublicationDecade 1990
PublicationTitle Cancer biotherapy & radiopharmaceuticals
PublicationYear 1998
References p_27
p_18
p_4
p_23
p_3
p_25
Griffiths GL (p_33) 1991; 51
Behr TM (p_16) 1995; 55
Oosterwijk E (p_24) 1995; 23
(p_15) 1994; 35
Holtzman E. (p_19) 1989
Geissler F (p_11) 1993; 52
Reist CJ (p_20) 1996; 56
p_31
Ebert T (p_26) 1990; 50
p_22
Duncan JR (p_34) 1997; 57
References_xml – volume: 51
  start-page: 4594
  year: 1991
  ident: p_33
  publication-title: Cancer Res
  contributor:
    fullname: Griffiths GL
– ident: p_27
  doi: 10.1016/0006-291X(78)91322-0
– ident: p_4
  doi: 10.1200/JCO.1996.14.7.1974
– ident: p_31
  doi: 10.1016/0022-1759(84)90435-6
– ident: p_18
  doi: 10.1002/(SICI)1097-0215(19970729)72:3<477::AID-IJC16>3.0.CO;2-9
– ident: p_22
  doi: 10.1002/(SICI)1097-0142(19971215)80:12+<2390::AID-CNCR9>3.0.CO;2-F
– volume: 23
  start-page: 253
  year: 1995
  ident: p_24
  publication-title: UrolRes
  contributor:
    fullname: Oosterwijk E
– volume: 55
  start-page: 3825
  year: 1995
  ident: p_16
  publication-title: Cancer Res
  contributor:
    fullname: Behr TM
– ident: p_23
  doi: 10.1002/ijc.2910380406
– volume: 56
  start-page: 4970
  year: 1996
  ident: p_20
  publication-title: Cancer Res
  contributor:
    fullname: Reist CJ
– volume: 52
  start-page: 2907
  year: 1993
  ident: p_11
  publication-title: Cancer Res
  contributor:
    fullname: Geissler F
– volume: 57
  start-page: 659
  year: 1997
  ident: p_34
  publication-title: Cancer Res
  contributor:
    fullname: Duncan JR
– ident: p_25
  doi: 10.1002/1097-0142(19930601)71:11<3478::AID-CNCR2820711104>3.0.CO;2-A
– ident: p_3
  doi: 10.1016/S0140-6736(95)92225-3
– volume: 50
  start-page: 5531
  year: 1990
  ident: p_26
  publication-title: Cancer Res
  contributor:
    fullname: Ebert T
– start-page: 95
  year: 1989
  ident: p_19
  publication-title: New York
  contributor:
    fullname: Holtzman E.
– volume: 35
  start-page: 899
  year: 1994
  ident: p_15
  publication-title: JNuclMed
SSID ssj0006067
Score 1.5073853
SourceID crossref
SourceType Aggregation Database
Index Database
StartPage 133
Title Tumor Retention of 186 Re-MAG3, 111 In-DTPA and 125 I Labeled Monoclonal Antibody G250 in Nude Mice with Renal Cell Carcinoma Xenografts
Volume 13
hasFullText
inHoldings
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bixMxFA5dBfFFdFVcL3AeZBHajJ37zGOta7tia9EKiy8l17WwO7PUFqm_wB_pj_Fkks6MqwurUIaSZFKa8-Xccs4JIc9NxkGQpoL6Oo9plLKY5lInVMh-ynPN0rwKoplMk_Gn6O1JfNLp_GxFLW3W3BPf_5pX8j9UxTakq8mS_QfK1pNiA35H-uITKYzP69F4c16ucIXWLmYRFT8_S7CBTgaj0Kwe8hhkAfT1fDaojglQ0eged98xjtJGmg1dirPKFzjAGXgpt90RaivGCTLdSGWC6pV11X5QZtTQePqG5vqhojxn3RNVmOgubatBtQoeCLXq8qVL7rIxOSsml-XFl7YHvVbnP65NWIlzfHsjr5YCKEhVgSg9tT1j7BvWva9KI1Uqrvm-1fxZnX5juFh0XMX1LC0mp96RN_EaH4dN-qtDYyxb7mcRRXvXnn8rx6pjlK9Z_DsvD1uYDVqM2bflNpyM920BpT_ERz8z1VcFX5kkzszzQ69-r12o-5IArcMaqwP9LF_gBAszwcIP8RPukb2qSJ_TD9BkTG3ah_1Pu4JTWf7y0i-3dKWW0jO_S-44awUGFnr3SEcV--TWxMVj7JPDmSXotgfzJpHvaw8OYdbURN_eJz8qqEINVSg1IFTBQbUHCFRwQAUEKiBQ4RgcUKEBKuyACgaosCzAABUMUMEAFSqgggEq1ECFBqgPyPzN0Xw4pu4SECqyJKS5SJjvp1KiWa4CyVUeJlqgmA4EQ90rD3ytpLkxW6Nmq2MecynRRmdRwHnQZ7z_kNwoykI9IuAzodE81yzOZSS1SRkPM9TOtEojHoj0gHi71V4IVyDf3NNytriCrgfkRf3Cha0Nc9XQx9cf-oTcbrbAU3JT43ZUz1DzXfNfAValrQ
link.rule.ids 786
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tumor+Retention+of+186+Re-MAG3%2C+111+In-DTPA+and+125+I+Labeled+Monoclonal+Antibody+G250+in+Nude+Mice+with+Renal+Cell+Carcinoma+Xenografts&rft.jtitle=Cancer+biotherapy+%26+radiopharmaceuticals&rft.au=Steffens%2C+M.G.&rft.au=Kranenborg%2C+M.H.G.C.&rft.au=Boerman%2C+O.C.&rft.au=Zegwaart-Hagemeier%2C+N.E.M.&rft.date=1998-04-01&rft.issn=1084-9785&rft.eissn=1557-8852&rft.volume=13&rft.issue=2&rft.spage=133&rft.epage=139&rft_id=info:doi/10.1089%2Fcbr.1998.13.133&rft.externalDBID=n%2Fa&rft.externalDocID=10_1089_cbr_1998_13_133
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1084-9785&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1084-9785&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1084-9785&client=summon